<p>The European Union has just suspended the sale of 700 Indian-made generic drugs. The decision came after Indian pharmaceutical research company GVK Bio was accused of allegedly manipulating the clinical trials. This is the latest in a series of scandals tarnishing the reputation of India's pharmaceutical industry, one of the world's heavyweight players in the domain. </p><br />Programme prepared by Patrick Lovett and Mariem Lina Fahoum<br /><br />Visit our website:<br />http://www.france24.com<br /><br />Like us on Facebook:<br />https://www.facebook.com/FRANCE24.English<br /><br />Follow us on Twitter:<br />https://twitter.com/France24_en
